Johnson & Johnson recalls 32 million boxes of Cilest birth control pill
Noting that the recall was a voluntary prevent measure, a J&J spokeswoman was quoted by Pharmalot as saying, "The risk to women is considered to be very low
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Calcium, natural vitamin D3, magnesium are present as precipitated calcium carbonate/cholecalciferol (vitamin D3)/magnesium carbonate combination in the tablets. The medication is indicated for the treatment and prevention of